Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
A six week, fixed dose, double-blind, double-dummy, placebo, and active controlled,
multicentre trial to evaluate the safety and efficacy of CP-316,311 in outpatients with major
depressive disorder.